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Available online 26 September 2018Background: Deﬁcient glucocorticoid biosynthesis leading to adrenal insufﬁciency is life-threatening and is asso-
ciated with signiﬁcant co-morbidities. The affected pathways underlying the pathophysiology of co-morbidities
due to glucocorticoid deﬁciency remain poorly understood and require further investigation.
Methods: To explore the pathophysiological processes related to glucocorticoid deﬁciency, we have performed
global transcriptional, post-transcriptional and metabolic proﬁling of a cortisol-deﬁcient zebraﬁsh mutant with
a disrupted ferredoxin (fdx1b) system.
Findings: fdx1b−/−mutants showpervasive reprogramming ofmetabolism, in particular of glutamine-dependent
pathways such as glutathione metabolism, and exhibit changes of oxidative stress markers. The glucocorticoid-
dependent post-transcriptional regulation of key enzymes involved in de novo purine synthesis was also affected
in this mutant. Moreover, fdx1b−/−mutants exhibit crucial features of primary adrenal insufﬁciency, and mirror
metabolic changes detected in primary adrenal insufﬁciency patients.
Interpretation: Our study provides a detailed map of metabolic changes induced by glucocorticoid deﬁciency as a
consequence of a disrupted ferredoxin system in an animal model of adrenal insufﬁciency. This improved path-
ophysiological understanding of global glucocorticoid deﬁciency informs on more targeted translational studies
in humans suffering from conditions associated with glucocorticoid deﬁciency.
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Glucocorticoids (GCs) are crucial regulators of important physiolog-
ical functions including metabolism [45]. Key steps in GC biosynthesis
require mitochondrial cytochrome P450 (CYP) type 1 enzymes that
are dependent on NADPH-derived electrons to catalyse their oxidative
reactions [58,59]. Mitochondrial electron transfer during GC biosynthe-
sis crucially relies on the iron-sulfur (Fe/S) protein ferredoxin
[adrenodoxin, (FDX1)] [58,59].
Mutations in steroidogenic enzymes involved in GC biosynthesis
cause a variety of inborn conditions in humans with associatedthe CC BY license (http://creativecommons.org/licenses/by/4.0/).
Research in context section
Impaired glucocorticoid biosynthesis severely impacts on
humanhealth. Thepathophysiologicalmechanismsof alteredme-
tabolism due to glucocorticoid deﬁciency are not precisely under-
stood and warrant further investigation. Such an endeavor is,
however, almost impossible in humans. Here, we employed a
zebraﬁshmutantwith impairedmitochondrial glucocorticoid bio-
synthesis to explore global changes in metabolites and gene ex-
pression at both the transcriptional and post-transcriptional
level. We have deﬁned glucocorticoid-dependent changes in sev-
eral metabolic pathways, including glutamine metabolism and
linked pathways such as glutathionemetabolism and de novo pu-
rine synthesis. Our study will help to focus clinical studies in rare
human conditions associated with glucocorticoid deﬁciency.
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have either a primary adrenal defect or suffer from secondary adrenal
insufﬁciency due to a problem in the pituitary gland. Both types of adre-
nal insufﬁciencies are linked to impaired health status including in-
creased mortality and morbidity as well as reduced quality of life in
patients [5,21,57]. Current GC replacement regimens in patients strug-
gle to replace GCs in a physiological manner and do not completely re-
store the health status [36]. This might be part of the observed health
problems in patients with adrenal insufﬁciency. However, only limited
information is available on global metabolic changes and pathway dys-
regulation in GC deﬁciency, which are likely to play a signiﬁcant role for
the observed pathophysiology and associated co-morbidity in humans.
Importantly, conditions associated with isolated GC deﬁciency in
humans are very rare. Therefore, research into the physiological role
of GCs and associated disorders greatly beneﬁts from animal in vivo
models allowing for comprehensive tissue sampling or application of
transgenic techniques unfeasible in humans.
The zebraﬁsh (Danio rerio) is awell-established vertebratemodel for
understanding gene function in embryonic development, disease, and
metabolism [35,50,67,68], including research on the endocrine system
and stress [53]. Similar to humans, zebraﬁsh are active during the day
and use cortisol as their main GC [53]. A fully functional stress axis lead-
ing to the release of cortisol by the interrenal gland, the ﬁsh counterpart
to the mammalian adrenal gland [53], is present at four to ﬁve days of
development [32,38,76]. Several zebraﬁsh mutants [19,23,33,60] and
transgenic reporter lines [6,8,24,28–30,37,44,63,75,76] of steroid hor-
mone synthesis and action have been established. They allow for com-
prehensive analysis of in vivo processes and for high-throughput
compound screenings to identify novel drug targets. Zebraﬁsh possess
two paralogues of the human FDX gene, fdx1 and fdx1b, with fdx1b
being speciﬁcally expressed in steroidogenic tissues [33,77] and serving
as the only relevant electron donor for mitochondrial steroidogenesis.
We have recently established an fdx1b zebraﬁsh mutant line
(fdx1b−/−) and showed that disruption of fdx1b leads to an impaired
stress response and severe global cortisol deﬁciency in larvae [33].
Here, we explore the in vivo metabolic consequences of GC deﬁ-
ciency due to a disrupted mitochondrial ferredoxin system in the
fdx1b−/−mutant zebraﬁsh line. The deﬁciency of multiple steps of GC
biosynthesis and the resulting severity of GC deﬁciency in the
fdx1b−/− mutants make this model particularly well suited for such
studies. A combination of transcriptomics and metabolic proﬁling in
fdx1b−/−mutants revealed an extensive reprogramming of metabolic
pathways, including glutamine metabolism as well as signiﬁcant
changes in the linked glutathione and purine biosynthesis pathways.
Remarkably, we identiﬁed post-transcriptional regulation of key en-
zymes underlying some of these changes. A comparison of the fdx1b−/
− mutants with a zebraﬁsh model of secondary adrenal insufﬁciency(rx3 strong) revealed both overlapping and distinct transcriptional
and metabolic changes in these two models of GC deﬁciency. Finally,
blood samples from individuals with primary adrenal insufﬁciency
showed altered amino acid concentrations consistent with the meta-
bolic alterations in our fdx1b−/−mutants, suggesting a translational rel-
evance to humans with GC deﬁciency.
2. Materials and methods
2.1. Zebraﬁsh husbandry
Adult zebraﬁsh (AB wild-type strain) were raised and bred accord-
ing to standard methods [79]. Embryos were obtained by natural
spawning and incubated at 28.5 °C in 1× E3 medium (5 mmol/l NaCl,
0.17 mmol/l KCl, 0.33 mmol/l CaCl2, 0.33 mmol/l MgSO4). The develop-
mental stages were determined in hours post-fertilization (hpf) as pre-
viously described [41]. All procedures were approved by the Home
Ofﬁce, United Kingdom and carried out in line with the Animals (Scien-
tiﬁc Procedures) Act 1986.
2.2. Phylogenetic analysis
The protein sequences of the examined genes (Table S1) were re-
trieved from ENSEMBL v84 (GRCz10) and phylogenetic analysis was
carried out as previously reported [40].
2.3. Treatment and sampling
fdx1b−/−mutants were identiﬁed due to their impaired visual back-
ground adaptation (VBA) at 96 hpf as previously described [33]. Larvae
(96 hpf) were exposed for 24 h with 25 μM Dexamethasone (DEX;
Sigma-Aldrich, #D1756) in E3 medium supplemented with 0.1%
DMSO.Wild-type embryos/larvae were treated with 1mMof the gluta-
minase inhibitor 6-Diazo-5-oxo-L-norleucine (DON; Sigma-Aldrich,
#D2141) in E3 medium at 72 hpf and 96 hpf for 24 h and 48 h, respec-
tively. For subsequent processing, larvae were either snap frozen in liq-
uid nitrogen at 120 hpf for RNA extraction or ﬁxed in 4%
paraformaldehyde for whole-mount in situ hybridization.
2.4. Total RNA extraction
20 larvae were sampled and homogenized in QIAzol lysis reagent
(Qiagen, # 79306) and stored overnight at−80 °C. Samples were then
passed several times through a syringe (BD Microlance, 0.5 × 25 mm,
#3086982), and RNA was extracted using the RNeasy Plus Universal
Kit (Qiagen, #73442) according to the manufacturer's instructions.
The integrity and quality of the total RNA was checked on an agarose
gel and NanoDrop spectrometer (Thermo Scientiﬁc). Only RNA with
A260/280 ratio ≥ 2 and A260/230 ratio ≥ 1 was used for subsequent
analysis.
2.5. cDNA synthesis and quantitative RT-PCR (qRT-PCR)
cDNA synthesis was carried out with 1 μg RNA using the SuperScript
VILO cDNA Synthesis Kit (LifeTechnologies, #11754-050). Expression
levels of the examined genes were examined with Power SYBRGreen
PCR Master Mix (Thermoﬁsher, #4367659) according to the manufac-
turers protocol. Primer sequences for the examined genes are listed in
Table S2.
2.6. Whole-mount in situ hybridization
Both the generation of probes using gene-speciﬁc oligos summa-
rized in Table S3 and whole-mount in situ hybridizations were carried
out as previously described [77]. cyp17a2 expression was used to deter-
mine the size of the interrenal gland using Image J software.
378 M. Weger et al. / EBioMedicine 36 (2018) 376–3892.7. Human study
Five participants with primary adrenal insufﬁciency followed at the
pediatric endocrinology clinic at Kanuni Sultan Süleyman Education
and Research Hospital were enrolled. All patients were on regular hy-
drocortisone treatment before the study. Patients were admitted to
the hospital and monitored for general well-being, heart rate, blood
pressure and blood sugar. Plasma samples were obtained after an over-
night fast between 7 and 9 a.m. at on-treatment state. After 48 h of dis-
continuation of hydrocortisone treatment plasma sampling was
repeated at fasting and off-treatment state at 7–9 a.m. Plasma samples
were frozen and stored at −80 °C until further analysis. Cortisol-
sufﬁcient (“On-treatment”) and cortisol-deﬁcient (“Off-treatment”)
states in patients were monitored by measuring plasma ACTH concen-
trations. No adverse events related to discontinuation of treatment for
48 h in the hospital settings were observed. The study design was ap-
proved by the local ethical committee (Approval number
10840098–604.01.01−E.4622). Written consent was obtained from
the families of the participating patients.
2.8. Next generation sequencing (RNA-seq)
RNA of 20 larvae (120 hpf; three biological replicates) was extracted
as described above. RNA integrity was checked with a 2100 Bioanalyzer
(Agilent). cDNA libraries were generated using the TruSeq Stranded
Total RNA Sample Prep Kit with the Ribo-Zero Gold depletion set
(Illumina) following themanufacturer's protocol. The libraries were se-
quenced on the Illumina Hiseq 2500 as single-end 50 base. Image anal-
ysis and base calling were performed using RTA 1.18.61 and bcl2fastq
1.8.2.
2.9. Metabolic proﬁling
2.9.1. 1H NMR spectroscopy
The metabolic study using NMR-Spectroscopy was carried out with
fdx1b−/− and wild-type siblings larval extracts (25 larvae/sample; at
least four biological replicates) as described in detail in [74].
2.9.2. PLC-FCS and IC-CD
Adenosine compounds, thiols and free amino acids were extracted
from 30 larvae (120 hpf, in ﬁve biological replicates) with 0.3 ml of
0.1 M HCl in an ultrasonic ice-bath for 10 min. The resulting homoge-
nates were centrifuged twice for 10min at 4 °C and 16.400 g to remove
cell debris. Adenosines were derivatized with chloroacetaldehyde as
previously described [9] and separated by reversed phase chromatogra-
phy on an Acquity BEH C18 column (150mm×2.1mm, 1.7 μm,Waters)
connected to an Acquity H-class UPLC system. Prior separation, the col-
umn was heated to 42 °C and equilibrated with 5 column volumes of
buffer A (5.7 mM TBAS, 30.5 mM KH2PO4 pH 5.8) at a ﬂow rate of
0.45 ml min-1. Separation of adenosine derivates was achieved by in-
creasing the concentration of buffer B (2/3 acetonitrile in 1/3 buffer
A) in buffer A as follows: 1 min 1% B, 1.6 min 2% B, 3 min 4.5% B,
3.7 min 11% B, 10min 50% B, and return to 1% B in 2 min. The separated
derivates were detected by ﬂuorescence (Acquity FLR detector, Waters,
excitation: 280 nm, emission: 410 nm, gain: 100) and quantiﬁed using
ultrapure standards (Sigma). Determination of amino acid levels was
done as described in Weger et al. [74]. Total glutathione was quantiﬁed
by reducing disulﬁdes with DTT followed by thiol derivatization with
the ﬂuorescent dye monobromobimane (Thiolyte, Calbiochem). For
quantiﬁcation of GSSG, free thiols were ﬁrst blocked by NEM followed
by DTT reduction and monobromobimane derivatization. GSH equiva-
lents were calculated by subtracting GSSG from total glutathione levels.
Derivatizationwas performed as described inWirtz et al. [82]. UPLC-FLR
analysis was carried out using the system described above. Separation
was carried out using the above described UPLC-FLR system with a bi-
nary gradient of buffer A (100 mM potassium acetate, pH 5.3) andsolvent B (acetonitrile) with the following gradient: 0 min 2.3% buffer
B; 0.99 min 2.3%, 1 min 70%, 1.45 min 70%, and re-equilibration to
2.3% B in 1.05 min at a ﬂow rate of 0.85 ml min-1. The column (Acquity
BEH Shield RP18 column, 50 mm× 2.1 mm, 1.7 μm,Waters) was main-
tained at 45 °C and sample temperature was kept constant at 14 °C.
Monobromobimane conjugates were detected by ﬂuorescence at
480 nm after excitation at 380 nm after separation.
For absolute quantiﬁcation by HPLC of amino acids in human blood
samples, ﬂuorescence derivatisation followed by separation with an
Acquity H-class UPLC system (Waters) and ﬂuorescence detection was
employed. Data acquisition and processingwas performedwith the Em-
power3 software suite (Waters). Organic acids were quantiﬁed by ion
chromatography and conductivity detection after cation suppression
with an ICS-3000 system (Dionex). Data acquisition and processing
was performed with the Chromeleon 6.7 software (Dionex).
2.10. Data analysis
2.10.1. RNA-seq data processing and analysis
Single-end readsweremapped onto the zebraﬁsh genome (GRCz10)
using STAR 2.3.8 [17]. A custom Perl script was used to count uniquely
mapped reads for each annotated gene locus (ENSEMBL v84) at both ex-
onic and intronic regions as described [4]. Data was analysed using
DESeq2 [54]. RNA-seq raw data for the rx3mutants was retrieved from
our previous study [74] available at NCBI's Gene Expression Omnibus
[20] (GSE76073) and reanalysed to assess differential gene expression
between rx3 strong (lack of eyes and GC-deﬁcient) and rx3weak mu-
tants (only lack of eyes). To assess the interaction between differential
expressed genes of fdx1b−/− mutants and rx3 mutants, we applied a
model to the counts of each gene: ~phenotype + mutated_gene
+ time + phenotype:mutated_gene (where mutated_gene is rx3 or
fdx1b, phenotype is wild-type or mutant and time is the Zeitgeber
time). To determine the statistical signiﬁcance for the interaction term,
we used a likelihood ratio test to compare the full model and a reduced
model that contains all experimental factor of the full model excluding
the interaction term (phenotype:mutated_gene).
Total RNA sequencing allows the quantiﬁcation not only of reads
mapped to exons (mRNA) but also of those mapped to introns (pre-
mRNA) [4,26]. To assess changes inmRNA and pre-mRNA level between
fdx1b−/− mutants and wild-type siblings, we applied the exon-intron
split analysis (EISA) described in [25]. The exon/intron ratio was used
as a proxy for relative mRNA half-life. Additional publicly available
RNA-seq based expression data [12,18,81] were analysed using
DESeq2 [54].
2.10.2. Gene set enrichment analysis
Gene sets were retrieved from GO ontology [64], KEGG based meta-
bolic pathways manually redeﬁned for zebraﬁsh [74], Ingenuity Path-
way Analysis (Qiagen) and MSigDB C2 canonical pathways [49]. We
deﬁned the gene set of ACTH targets from [84]. To perform gene set en-
richment analysis for differentially expressed genes and interaction be-
tween rx3 strong and fdx1b−/− mutants, we employed the camera
function of the limma package [83] using linear model experimental
factors detailed in RNA-seq data processing and analysis. Gene set en-
richment analysis was visualized using barcode plots of the limma pack-
age [83]. Brieﬂy, t-stats from the linear model were ranked from largest
to smallest (from left to right). The position of the chosen gene set are
marked by vertical bars representing a barcode. The relative enrichment
of the vertical bars is depicted by enrichment worm above the barcode.
2.10.3. NMR based data and metabolic proﬁling
Data were log transformed for HPLC based methods or a variance
stabilizing transformation was applied to the data from the NMR
based measurements [42]. We subsequently ﬁt a linear model
~genotype*treatment for each metabolite (HPLC based) or each peak
(NMR) (Table S4). Metabolite differences between patients under On-
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effects model. To this end, a full model was ﬁtted to the data: y ~ age
+ treatment+ (1|ID), where y is the log2 normalized serumconcentra-
tionwith a speciﬁc age at treatment condition (On/Off). 1|ID represents
a patient speciﬁc random effect on the baseline. The full model was
compared to a reduced model (y ~ age + (1| ID)) using a likelihood
ratio test.
2.10.4. Multiple testing
All p-values presented in this manuscript were corrected for multi-
ple testing using the method of Benjamini-Hochberg [7], if applicable.
2.11. Data availability
The data generated for this publication have been deposited in
NCBI's Gene Expression Omnibus [20] and are accessible through GEO
Series accession number GSE107547 and are available in Table S5.
Reanalysed rx3 strong data are available in Table S6.
3. Results
3.1. Disruption of ferredoxin leads to profound transcriptional alterations in
several metabolic pathways
The potential dysregulation of gene expression as a consequence of
GC deﬁciency in fdx1b−/− mutants was analysed by RNA-seq from
total RNA obtained from fdx1b−/− and wild-type sibling larvae at 120
hpf. The RNA-seq showed a high biological reproducibility as demon-
strated by the strong correlation between biological replicates (R ≥
0.0993; Fig. S1A). Overall, the differential gene expression analysis iden-
tiﬁed a down-regulation of 446 and an up-regulation of 432 genes in the
fdx1b−/− larvae (adjusted p-value ≤.01, |log2Fold change| ≥ 0.25; Fig. 1A
and Table S5). By employing an enrichment analysis based on gene on-
tology categories themost prominent functions in the fdx1b−/− gene set
were identiﬁed. Down-regulated genes in fdx1b−/− larvae were
enriched in pathways for ion transport including sodium ion transmem-
brane transporter activity, voltage gated cation and ion channel activity
(Fig. 1B). These ﬁndings appear to be consistent with the role of GCs in
the osmoregulation in ﬁsh larvae [71]. In contrast, we observed an en-
richment of up-regulated genes in a broad range of metabolic pathways
in fdx1b−/− mutants. This included pathways of lipid localization and
transport, organic hydroxy compound transport as well as processes
of alcohol, co-factor and haemoglobin metabolism (Fig. 1B). In addition,
up-regulated genes were enriched in DNA replication and cell cycle as-
sociated pathways (Fig. 1B and Table S7), supporting the observed im-
portance of GCs for circadian regulation of cell proliferation in
zebraﬁsh larvae [16]. A furthermore speciﬁc analysis of metabolic path-
ways based on KEGG annotation [74] identiﬁed an expected compensa-
tory up-regulation of genes involved in steroid hormone synthesis in
response to the disrupted steroidogenesis (Fig. 1B). In addition, an en-
richment of pathways of energy metabolism was detected, which in-
cluded the pentose phosphate cycle, pyruvate metabolism and
synthesis as well as ketone degradation (Fig. 1B). Also, pathways lead-
ing to the degradation of the amino acids valine, leucine, and isoleucine
and the metabolism of tryptophan, histidine, glycine, serine, and threo-
nine were found to be up-regulated. In addition, we found an up-
regulation of the folate mediated one‑carbon metabolic pathway, of
glyoxylate and dicarboxylate metabolism, of purine metabolism, and
of glutathionemetabolism (Fig. 1B). Overall, the systemic GC deﬁciency
in fdx1b−/− mutant larvae resulted in an extensive transcriptional
reprogramming of genes involved in a widespread set of metabolic
pathways. In addition to anticipated pathways directly or indirectly
linked to energy metabolism, also crucial biosynthetic pathways such
as purine biosynthesis and the redox-buffering glutathionemetabolism
were affected.3.2. fdx1b−/− larvae exhibit speciﬁc glucocorticoid-dependent metabolic
alterations
An untargeted 1H NMR spectroscopy analysis with aqueous larval
extracts of fdx1b−/−mutants and wild-type siblings was performed to
assess if observed transcriptional changes in fdx1b−/− mutants affect
metabolite concentrations. Principal component analysis (PCA) indi-
cated clear differences in the metabolome between the fdx1b−/− mu-
tants and their wild-type siblings (Fig. 2A). To understand the GC-
dependent metabolic changes in fdx1b−/− mutants, we also analysed
larvae treated with the synthetic GC dexamethasone (DEX). DEX treat-
ment led to a general shift of the 1H NMR spectra along principal com-
ponent (PC) 1, and a closer clustering of the fdx1b−/−mutant with the
control metabolome along PC2 (Fig. 2A). This suggests that GC treat-
ment can rescue some of the changes observed in fdx1b−/− larvae. To
identify the main metabolites altered by GC deﬁciency in fdx1b−/− lar-
vae, we calculated the ratio of changes in mutants in the absence and
presence of DEX for each NMR feature. This ratio indicates the extent
of altered differences by GC treatment between fdx1b−/− larvae and
wild-type siblings. The statistical signiﬁcance of this ratio was deter-
mined by calculating the interaction termbetween treatment and geno-
type. Following this approach,we identiﬁed several signiﬁcantly altered
peaks, including those at 2.46 ppm and 1.48 ppm corresponding to glu-
tamine and alanine, respectively (Fig. 2B and C). The abundance of glu-
tamine increased, whereas alanine decreased in untreated fdx1b−/−
larvae. The intensities of all identiﬁed peaks were different to the
wild-type in untreated fdx1b−/− mutants, whereas wild-type and
fdx1b−/− mutants showed similar patterns after DEX treatment
(Fig. 2C), indicating GC-dependent rescue of the differences. Notably,
both glutamine and alanine can serve as substrates for gluconeogenesis
[10], and thus are highly relevant for endogenous glucose production.
Glutamine also acts as key nitrogen source for the synthesis of biomol-
ecules such asnucleotides andother amino acids [13]. Therefore, the ob-
served alterations in these amino acids indicate a dysregulation of
energy metabolism and synthesis of biomolecules in GC-deﬁcient
fdx1b−/− larvae and conﬁrm the relevance of observed changes de-
tected on transcriptomic level. By using targeted HPLC-based metabolic
proﬁling, we expanded the assessment of metabolites to other amino
acids and nucleotides (Table S4). This analysis conﬁrmed the GC-
dependent decrease in alanine and the increase in glutamine concentra-
tions (Fig. 3A and C). In addition, histidine, which is degraded in a path-
way eventually leading to the formation of glutamate, shows decreased
concentrations in fdx1b−/− mutants (Fig. 3C). Expression of the genes
encoding for the enzymes involved in these linked pathways broadly
correlatedwith observedmetabolite changes in fdx1b−/−mutant larvae
(Fig. 3A and B).
3.3. Glutamine metabolism and linked pathways are affected in fdx1b−/−
mutant larvae
Our explorative and untargeted analyses implied a key role of the
metabolism of glutamine as a dysregulated pathway by GC deﬁciency.
As glutamine and glutamate is linked with other major affected path-
ways including energy metabolism as well as glutathione and purine
metabolism, we focussed on the metabolism of glutamine and gluta-
mate. In mammals, glutamine synthetase (GLUL) is responsible for the
synthesis of glutamine from glutamate, whereas two glutaminases
(GLS andGLS2) are responsible for glutaminolysis of glutamine into glu-
tamate [2] (Fig. S2A). In silico, three paralogs of glutamine synthetase
(Glula, Glulb, Glulc), two paralogs of glutaminase (Glsa, Glsb) and two
paralogs of glutaminase 2 (Gls2a, Gls2b) as well as an additional novel
Ensembl prediction termed Glsl were identiﬁed in zebraﬁsh. The phylo-
genetic analysis demonstrates clustering of the zebraﬁsh glutamine
synthetase and glutaminase proteins, except for Glsl, with their respec-
tive orthologs in humans, mice and rats (Fig. S2B). This ﬁnding suggests
a conserved function of glutamine metabolism between vertebrates.
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glul genes, was signiﬁcantly different between fdx1b−/− larvae and
wild-type siblings (Fig. 3D and Table S5). Since zebraﬁsh larvae are
not free feeding at the examined stage, increased glutamine concentra-
tions in fdx1b−/− mutants are likely to be caused by impaired
glutaminolysis due to reduced expression and function of glutaminases
(gls2a and gls2b). qRT-PCR of wild-type and fdx1b−/− larvae raised in
the absence or presence of DEX demonstrated a signiﬁcant down-
regulation of both gls2a and gls2b in fdx1b−/− larvae with an up-
regulation in response to DEX treatment (Fig. 3E). This ﬁnding suggests
GC-dependent gene expression of the gls2a and gls2b genes. To better
understand the physiological relevance of the affected glutaminase
paralogs, the spatio-temporal expression of gls2a, gls2b, glsl, glsa and
glsb was analysed. The reanalysis of a previously published develop-
mental transcriptome data set including data from zygote stage to 120
hpf [81] showed that all glutaminases were expressed in larvae at 120
hpf with a maternal contribution mainly for glsb and gls2a (Fig. S2C).
Whole-mount in situ hybridization in 120 hpf wild-type larvae showed
speciﬁc gls2a expression in the liver, whereas gls2b is expressed in both
liver and intestine (Fig. S2D). The other paralogsweremainly expressed
in the larval brain (glsa, glsb) or in the swim bladder (glsl, glsb)
(Fig. S2D). These data suggest that increased glutamine concentrations
in fdx1b−/− mutant larvae is resulting from impaired glutaminolysis
due to impaired GC-dependent transcription of liver and intestine spe-
ciﬁc glutaminases (gls2a and gls2b).
3.4. fdx1b−/− mutants show profound changes in glutathione metabolism
and markers of oxidative stress
The most enriched metabolic pathway in the fdx1b−/−mutants was
glutathione metabolism (Fig. 1B; adj. p-value = 1.52E-11). Glutathione
(GSH) is an antioxidant and a cellular signallingmolecule, which is used
by glutathione S-transferases (GSTs) to detoxify reactive oxygen species
(ROS) [22]. The vast majority of GSTs were up-regulated in fdx1b−/−
mutants (Fig. 4A and B) suggesting increased oxidative stress levels in
fdx1b−/− larvae. On the biochemical level, increased concentrations of
glutathione disulphide (GSSG) and a decrease in the GSH to GSSG
ratio as marker of increased oxidative stress [22] were observed in the
fdx1b−/− mutants (Fig. 4C). These ﬁndings are further supported by a
decrease of the antioxidant taurine and an increase of cysteine in
fdx1b−/− larvae (Fig. 4C). In addition, the majority of Nrf2 (nuclear fac-
tor E2-related factor 2) target genes were up-regulated in fdx1b−/− lar-
vae (Fig. S3A and B). Since Nrf2 is the master regulator of genes
mediating the response to oxidative stress [22], this ﬁnding is highly
suggestive for systemically elevated oxidative stress levels in fdx1b−/−
mutants. Importantly, DNA damage caused by oxidative stress has
been implicated in human pathology [69]. Consistent with the detected
increased levels of oxidative stress in fdx1b−/− mutants, genes impli-
cated in double-strand break induced DNA repair (i.e., nonhomologous
end joining and homologous recombination) are signiﬁcantly up-
regulated in fdx1b−/−mutants (Fig. S3C and D).
Remarkably, the increased transcript levels of the Nrf2 key target
gene fth1a [11] and the antioxidant gene duox returned to wild-type
levels by DEX treatment in fdx1b−/− larvae (Fig. S3E), indicating an im-
portant role of GCs in the altered oxidative stress levels. However, on
the biochemical level, GSH, GSSG and taurine concentrations remained
signiﬁcantly different between wild-type and mutant larvae after DEX
treatment (Fig. 4C), indicating that GC deﬁciency might not be the
only cause of altered oxidative stress levels in fdx1b−/−mutants.
3.5. Expression of key enzymes of de novo purine synthesis pathway is reg-
ulated by glucocorticoids
Another enriched metabolic pathway in the fdx1b−/−mutant larvae
was the glutamine-dependent de novo purine synthesis pathway
(Fig. 1B; adj. p-value = 2.54E-2). In fact, two enzymes of this pathway,paics and atic (Fig. 5A and B), were among the ﬁve most highly up-
regulated genes in the transcriptome analysis (Table S5). Interestingly,
the only four additional differentially expressed genes of de novo purine
synthesis leading to inosine monophosphate (IMP) were all signiﬁ-
cantly up-regulated in fdx1b−/− mutants (Fig. 5A and B). Several en-
zymes of purine metabolism downstream of IMP also showed an
altered mRNA abundance in fdx1b−/− mutants (Fig. 5A and B), but no
clear trend for global up- or down-regulation of these genes was de-
tected. However, on the biochemical level, both guanosine
monophosphate (GMP) and adenosine diphosphate (ADP) concentra-
tions were signiﬁcantly increased in fdx1b−/− larvae (Fig. 5C). Differ-
ences between mutants and wild-type sibling larvae were decreased
under DEX treatment, thus indicating the GC-dependency of these
metabolites.
3.6. paics and atic are regulated by glucocorticoids in a post-transcriptional
manner
The consequences of GC deﬁciency for altered post-transcriptional
gene regulation were explored by employing an exon-intron split anal-
ysis (EISA) [4,26]. Due to the generally lower read coverage of intronic
reads, the number of differentially expressed genes at pre-mRNA level
is slightly lower than genes at mRNA level (Fig. 5D). The correlation be-
tweenmRNA and pre-mRNA changes was high (Fig. 5E) indicating that
differentially expressed genes in GC-deﬁcient fdx1b−/− larvae are pre-
dominantly regulated at the transcriptional level. To identify post-
transcriptionally regulated genes, we aimed to identify genes showing
signiﬁcantly higher changes in mRNA level (ΔmRNA) than changes in
transcription (Δpre-mRNA). By following this approach, paics and atic
were identiﬁed to have positive and signiﬁcantΔmRNA/Δpre-mRNA ra-
tios in fdx1b−/− larvae (Fig. 5E).When using themRNA/pre-mRNA ratio
as a proxy for mRNA half-life [4], both paics and atic showed a signiﬁ-
cantly higher mRNA stability in fdx1b−/− larvae than in wild-type sib-
lings (Fig. 5F). Treatment of fdx1b−/− larvae with DEX reduced the
mRNA of paics and atic back to levels observed in wild-type without
changingpre-mRNA levels (Fig. 5G), indicating the increasedmRNA sta-
bility of paics and atic in fdx1b−/−mutants is a consequence of GC deﬁ-
ciency. Given the importance of glutamine for de novo purine synthesis
(Fig. 5A), we explored if the observed changes in glutaminemetabolism
with down-regulation of gls2a and gls2b in fdx1b−/−mutants are linked
to the altered mRNA stability of paics and atic. Therefore, Gls was phar-
macologically inhibited using 6-Diazo-5-oxo-L-norleucine (DON) in
wild-type larvae to mimic the alteration in glutamine metabolism ob-
served in fdx1b−/− mutants. 48 h of DON treatment signiﬁcantly in-
creased glutamine and decreased glutamate levels in wild-type larvae
(Fig. 5H). Importantly, this treatment led to a selective increase in
paics mRNA levels, whereas atic mRNA levels and the transcriptional
rate of either gene remained unchanged (Fig. 5I).
To assess the relevance of glutamine concentrations in the observed
effects, we analysed mRNA levels of paics and atic in a transgenic
zebraﬁsh model expressing an activated form of the Hippo pathway ef-
fector yap1 [12]. Yap reprograms glutaminemetabolism to increase nu-
cleotide biosynthesis and these animals show increased GluI activity
and subsequently elevated glutamine concentrations. Similar to the
DON-treated larvae, only paics was differentially expressed in yap1
transgenic zebraﬁsh (Fig. S4A). Surprisingly, despite increased gluta-
mine concentrations the levels of paicsmRNA were signiﬁcantly lower
in yap1 transgenic zebraﬁsh than in wild-type (Fig. S4A). This observa-
tion suggests that glutamine accumulation is not directly resulting in in-
creased paicsmRNA stability.
miRNAs are a prominent class of post-transcriptional regulators [34].
Therefore, we analysed differential gene expression ofmiRNAs between
fdx1b−/− mutant and wild-type sibling larvae which we were able to
detect in the total RNA-seq data set. dre-mir-2192was the only detected
miRNA,whichwas up-regulated in fdx1b−/−mutant larvae (adjusted p-
value= .02; Fig. S4B). To test whethermiRNAs affect gene expression of
Fig. 1. fdx1b−/−mutants show an extensive transcriptional reprogramming of energy and biomolecule generating metabolic pathways. (A) Heatmap of normalized mRNA expression
levels of genes in fdx1b−/−mutant larvae and wild-type siblings. Red, high expression; blue, low expression. From in total 878 differentially expressed genes, 446 genes were down-
regulated, and 432 genes were up-regulated in fdx1b−/− mutant larvae. (B) Gene set enrichment analysis of differentially expressed genes (fdx1b−/−vs. wild-type sibling larvae).
Direction indicates whether the up- or down-regulated genes in fdx1b−/−mutants are enriched for the indicated term.
Fig. 2.Untargeted 1HNMRspectroscopy analysis reveals changes in themetabolome of fdx1−/−mutant larvae. (A) Principal component analysis (PCA) score plots of the 1HNMR spectra of
fdx1b−/−mutant and wild-type sibling larvae treated with dexamethasone (DEX) or vehicle as control (CTR). (B) Volcano plot represents the difference in fold change for each peak
between fdx1b−/− and wild-type sibling larvae under DEX and CTR treatment. Signiﬁcant peaks are labeled. (C) Heatmap of peaks with a signiﬁcant interaction. Red = high
expression; blue= low expression. The assignedmetabolites including glutamine and alanine are altered in fdx1b−/−mutant larvae under basal conditions, but not upon DEX treatment.
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Fig. 3. fdx1b−/− mutant larvae exhibit alterations in gene expression related to alanine, aspartate and glutamate metabolism and in glutamine-family amino acids. (A) Schematic
represents “alanine, aspartate and glutamate metabolism”, and glutamine-family amino acids. Altered metabolites and genes in fdx1b−/− larvae are indicated in red for up-regulation
and blue for down-regulation. (B) Heatmap showing differentially expressed genes of alanine, aspartate and glutamate metabolism in fdx1b−/− mutant larvae. (C) HPLC-based
measurements of metabolite levels of alanine (Ala), glutamine (Gln) and histidine (His) in fdx1b−/−mutant larvae and wild-type siblings in the in the absence (CTR) or presence of
dexamethasone (DEX). (D) Fold change of glutamate metabolism genes of fdx1b−/−vs. wild-type sibling larvae. (E) qRT-PCR analysis of the zebraﬁsh gls2a and gls2b in fdx1b−/−
mutant larvae and wild-type siblings (120 hpf) in the absence (CTR) or presence of dexamethasone (DEX).
Fig. 4.Dysregulations in glutathionemetabolism andmarkers of oxidative stress in fdx1b−/−mutant larvae are only partially caused by glucocorticoid-deﬁciency. (A) Schematic illustrates
“glutathione metabolism”. Metabolites and genes of this pathway altered in fdx1b−/− larvae are marked in red for up-regulation and blue for down-regulation. (B) Heatmap showing
differentially expressed genes of glutathione metabolism in fdx1b−/−mutant larvae. (C) Metabolite levels of cysteine (Cys), reduced (GSH) and oxidized (GSSG) glutathione, taurine
and the GSH/GSSG ratio as a measure of oxidative stress in fdx1b−/−mutant and wild-type sibling larvae in the absence (CTR) or presence of dexamethasone (DEX).
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Fig. 5. Glucocorticoids regulate de novo purine synthesis at a post-transcriptional level. (A) Schematic of the “purinemetabolism” pathway. Metabolites and genes of this pathway altered
in fdx1b−/− mutant larvae are marked in red for up-regulation and blue for down-regulation. (B) Heatmap showing differentially expressed genes of purine metabolism in fdx1b−/−
mutant larvae. (C) Metabolite levels of guanosine monophosphate (GMP) and adenosine diphosphate (ADP) in fdx1b−/−mutant and wild-type sibling larvae (120 hpf) in the absence
(CTR) or presence of dexamethasone (DEX). (D) Number of differentially expressed genes in function of the adjusted p-value grouped by the different levels at which they were assessed.
mRNA (black), pre-mRNA (red), and genes that are differentially affected betweenmRNA and pre-mRNA (blue). (E) Comparison of pre-mRNA andmRNA expression changes in fdx1b−/−
mutant larvae. R indicates Pearson correlation. Signiﬁcantly deregulated genes at the level of Δexon-Δintron are labeled green. Predominantly post-transcriptional (ΔexonNΔintron) al-
tered genes are shown in red. (F) mRNA half-life approximation of paics and atic in fdx1b−/− mutant and wild-type sibling larvae. (G) qRT-PCR analysis assessing mRNA and pre-
mRNA levels of paics and atic in fdx1b−/−mutant and wild-type sibling larvae (120 hpf) in the absence (CTR) or presence of dexamethasone (DEX). (H, I) Glutamine (Gln) and glutamate
(Glu) levels (H) and transcript levels of paics and atic (I) in wild-type larvae treated with the glutaminase inhibitor 6-Diazo-5-oxo-L-nor-Leucine (DON) or vehicle as a control (CTR).
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384 M. Weger et al. / EBioMedicine 36 (2018) 376–389atic and paics, we re-analysed a previously published RNA-seq data set
of a murine DICER knock-out model with a liver-speciﬁc inactivation
of miRNA biogenesis [18]. A small decrease in transcription and mRNA
abundance of paics in DICER knock-out mice was observed (Fig. S4C),
whilst aticmRNA abundance showed a stronger down-regulation. atic
transcription as indicated by pre-mRNA abundance was not as strongly
reduced asmRNA abundance (interaction p-value= .03; Fig. S4C), sug-
gesting that atic is post-transcriptionally regulated by miRNAs. These
data are consistent with a stabilization of aticmRNA due to miRNA de-
pendent effects also in the zebraﬁsh. Altogether, fdx1b−/− larvae
showed a pervasive reprogramming of purine metabolism, leading to
changes of purine metabolite concentrations. In addition, we provide
the ﬁrst evidence for GC-dependent post-transcriptional regulation of
key factors in purine synthesis.
3.7. fdx1b−/− mutants exhibit systemic changes distinct from a secondary
adrenal insufﬁciency-like phenotype
To explore if metabolic changes observed in fdx1bmutant larvae are
solely explained by the lack of GCs, we compared the results obtained
from the fdx1−/− larvae to rx3 strong mutant larvae, another model
for GC deﬁciency. Therefore, we reanalysed our recently published rx3
strong mutants RNA-seq data set ([74]; Fig. S5 and Table S6). fdx1b-/-
mutant larvae present a phenotype similar to primary adrenal insufﬁ-
ciency in humans, including cortisol deﬁciency, down-regulation of
GC-dependent marker genes, an up-regulation of the HPI axis ([33];
Fig. 6A) and interrenal hyperplasia (Fig. 6B). In contrast, the rx3 strong
mutant larvae show a profoundly impaired synthesis of GCs due a re-
duction in ACTH-producing corticotrope cells ([16]; Fig. 6A). Indeed,
ACTH target genes are mainly up-regulated in fdx1b−/−mutants (p=
.008) and down-regulated in rx3 strong mutants (p = .006) (Fig. 6C).
These ﬁndings conﬁrm the assumption that fdx1bmutant larvae resem-
ble a primary adrenal insufﬁciency phenotype and that rx3 strong mu-
tants can be used to model secondary adrenal insufﬁciency. Thus, we
subsequently explored if these two zebraﬁsh models of adrenal insufﬁ-
ciency differ on a global gene expression level. A statistical model in-
cluding an interaction term between the mutant type and the
phenotype was employed to extract the differences between gene ex-
pression changes in the fdx1b−/− and rx3 strong models compared to
their respective controls. The next step assessed which GO term and
KEGG-based metabolic gene sets were enriched in the differentially
expressed genes with a signiﬁcant interaction term. Pathways such as
the ornithine urea cycle and branched-chain amino acids show the
same changes in both mutants (see [74] for the rx3 strong and Fig. S6
for the fdx1b−/− mutants). However, several metabolic pathways
showed enrichment for differences between fdx1b−/− and rx3 strong
mutants (Fig. 6D and E). These pathways include sterol biosynthesis
and steroid hormone biosynthesis (Fig. 6D–F). Consequent with the de-
tected changes in ACTH levels, steroid hormone biosynthesis genes are
up-regulated in fdx1b−/− and down-regulated in rx3 strong mutants
(Fig. 6E and F).
Furthermore, glutathione metabolism was identiﬁed as a pathway
with major alterations (Fig. 6D and E). Interestingly, GC-deﬁcient
fdx1b−/− mutants show an overall up-regulation (p = 1.52E-11),
whereas rx3 strong mutants show no clear global up- or down-
regulation of glutathione metabolism-associated genes despite having
the same level of GC deﬁciency as the fdx1b−/− larvae. Consistent withFig. 6. fdx1b−/−mutant larvae exhibit hallmarks of primary adrenal insufﬁciency and differ fro
shows the different alterations in the pituitary and interrenal gland axis of fdx1b−/− a
adrenocorticotropin; SG, steroidogenesis. (B) Whole-mount in situ hybridization of cyp17a2
type siblings (n = 11) at 120 hpf stage. Bar plot shows the relative (rel.) changes in the dia
mutant larvae (left) and rx3 strong mutant larvae (right). The two mutant types show oppos
analysis. (D) Gene set enrichment analysis of differentially expressed genes showing differen
and Nrf2 target genes in fdx1b−/− mutant larvae (left) and rx3 strong mutant larvae (right)
changes of differentially expressed genes in steroid hormone biosynthesis between mutant la
our previously published data set [74]. Scale bar = 110 μm. *, p b .05, **, p b .01, ***, p b .001.differential redox metabolism changes in the two mutants, Nrf2 target
genes were mainly down-regulated in rx3 strong mutants (Fig. S3A
and Table S6), in contrast to the fdx1b−/− situation (Fig. S3A). This fur-
ther supports the conclusion reached above that the observed higher
oxidative stress levels in fdx1b−/− mutants are only partially caused
by the lack of GCs. Importantly, several other metabolic pathways, in-
cluding tryptophanmetabolism; valine, leucine and isoleucine degrada-
tion; purinemetabolism; alanine, aspartate and glutamate metabolism;
and terpenoid backbone synthesis differ between bothmutants (Fig. 6D
and E). Overall, our data show profound global differences in the two
types of GC deﬁciency models. Thus, such pathophysiological differ-
ences inmodels of GC deﬁciencymightmost probably be caused by dys-
regulation of other pathways and factors associated with the speciﬁc
cause of impaired GC synthesis rather than only cortisol deﬁciency.
3.8. Patients with adrenal insufﬁciency show similar amino acid changes as
fdx1b−/− zebraﬁsh mutants
To explore if humans with primary adrenal insufﬁciency have simi-
lar metabolic changes as observed in fdx1b−/−mutants, we performed
targeted metabolic proﬁling of amino acids on blood samples from chil-
dren with primary GC deﬁciency (Fig. 7A). Off treatment, patients
showed changes in asparagine, lysine, phenylalanine, alanine, histidine,
arginine, leucine and methionine concentrations (Fig. 7B). These data
indicate that amino acid metabolism is strongly affected when GC re-
placement is insufﬁcient. Interestingly, alanine, arginine, leucine,methi-
onine and phenylalanine concentrations are also lower in untreated
fdx1b−/− larvae compared to DEX-treated fdx1b−/− larvae (Fig. 7C and
Table S4). A smaller similarity was observed when comparing the data
to rx3 strong mutants. Histidine and methionine were the only two
out of the eight amino acids altered in patients, being similarly affected
in rx3 strong mutants (Fig. 7C and Fig. S7). Thus overall, the metabolic
proﬁles in patients with primary adrenal insufﬁciency correlate better
with the metabolic proﬁle observed in fdx1b−/− mutants than with
that of rx3 strongmutants. This further shows that there are differences
between both types of GC deﬁciency models and that the fdx1b−/−mu-
tant recapitulates more closely metabolic changes of patients with pri-
mary adrenal insufﬁciency.
4. Discussion
By combining transcriptomics and metabolic proﬁling, we detected
reprogramming of metabolism, such as glutamine metabolism in GC-
deﬁcient fdx1b−/− mutant larvae. In line with this observation, gluta-
mine concentrations were increased in fdx1b−/− mutant larvae. Due
to the relevance of glutamine for several linked metabolic pathways
[13] which were also affected in fdx1b−/− mutants, we further
characterised these pathways in the zebraﬁsh model. Notably, we pro-
vide the ﬁrst spatio-temporal characterization of the zebraﬁsh gluta-
minase and glutamine synthetase genes at embryonic/larval stages,
whereas some data on the synthetases are available in adult zebraﬁsh
[14]. Thus, our analysis provides a valuable source for future investiga-
tion into the role of glutamine in cancer development and growth
[2,13] using the zebraﬁsh model [51,80]. Importantly, gls2a and gls2b
were the only differentially expressed genes in glutaminolysis or syn-
thesis in fdx1b−/−mutants, and were also responsive to GC treatment.
This ﬁnding supports the GC dependent regulation of the diurnalm rx3 strong mutant larvae reminiscent to secondary adrenal insufﬁciency. (A) Schematic
nd rx3 strong mutant larvae. Abbreviations: Pomca, pro-opiomelanocortin; ACTH,
to visualize the interrenal gland (arrow) in fdx1b−/− mutant larvae (n = 17) and wild-
meter of the interrenal gland size. (C) Barcode plots for ACTH target genes in fdx1−/−
ing directions in the gene set enrichment (p-value = 1.7 E−04) for gene set enrichment
t regulation between fdx1b−/− and rx3 strong. (E) Barcode plots for metabolic pathways
in comparison to the corresponding control (wild-type siblings or rx3 weak). (F) Fold
rvae and their corresponding controls. The data for the rx3mutants is a reanalysis from
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glutaminolysis by GCs. The GC dependent regulation of gls2a and
gls2b, and the fact that zebraﬁsh are not self-feeding at the examined
stages, strongly suggests that increased glutamine levels in fdx1b−/−
mutant larvae are likely to be caused by impaired glutaminolysis rather
than by impaired glutamine synthesis.
Importantly, data on global metabolic changes in patientswith adre-
nal insufﬁciency are limited. Our clinical data obtained from patients
with primary adrenal insufﬁciency indicate metabolic alterations simi-
lar to observed changes in our fdx1b-deﬁcient larval model. However,
plasma of untreated patients does not show the major accumulation
of glutamine detected in fdx1b−/−mutants. As glutamine metabolism
involves several organs [73], the difference may be due to the larger
set of tissues analysed in thewhole larval extracts, but could also reﬂect
species-speciﬁc differences in, for example, nitrogenic waste excretion
[72]. Nevertheless, eight other amino acids showed lower plasma con-
centrations in untreated patients, and ﬁve of these were also lower in
untreated fdx1b−/−mutants compared to DEX treatment. Furthermore,
two of these amino acids were also changed in plasma samples of con-
genital adrenal hyperplasia (CAH) patients under GC replacement ther-
apy [3]. Asparagine and methionine were lower in patients with CAH
treated with lower GC doses than in those receiving high doses of GC.
Furthermore, the purine inosine was increased in patients receiving
low dose GC treatment [3]. This correlates with the observed metabolic
and broad transcriptional as well as post-transcriptional up-regulation
of purine metabolism observed in untreated fdx1b−/− mutants. Of
note, the metabolic alterations in patients with primary adrenal insufﬁ-
ciency show greater overlap with those seen in the fdx1b−/− mutant
than with those in rx3 mutants. This observation indicates that such
changes may be speciﬁc to primary adrenal insufﬁciency as opposed
to conditions associated with secondary adrenal insufﬁciency. Overall,
by determiningmetabolic alterationsmost likely speciﬁc to primary ad-
renal insufﬁciency, our study expands the understanding intometabolic
changes in patients with primary GC deﬁciency. Furthermore, overlap-
ping alterations in larvae validate fdx1b−/−mutant as a model for met-
abolic features of primary adrenal insufﬁciency.
To explore potential changes between primary and secondary adre-
nal insufﬁciency, we compared our results from the fdx1b−/− mutant
with our previously published data set of rx3 strong mutants [74],
which represents a model of secondary adrenal insufﬁciency. This anal-
ysis showed clear differences in changed gene expression in the two
systems consistent with the different causes of GC deﬁciency. Down-
regulation of ACTH target gene expression and steroidogenic genes ex-
pression in the ACTH-deﬁcient rx3 strong model, in contrast to the up-
regulation observed in fdx1b−/− mutants, support the notion that
these different lines representmodels of secondary and primary adrenal
insufﬁciency, respectively. Furthermore, we found striking differences
in the metabolic proﬁles between the rx3 strong and fdx1b−/−mutants.
This includes glutathione metabolism, which was the most affected
pathway in fdx1b−/−mutants. The observed changes in glutathioneme-
tabolism suggest altered levels of oxidative stress, which have been im-
plicated in pathogenesis by leading to metabolic dysfunction [46] or
DNA lesions [69]. The up-regulation of Gst genes and Nrf2 target
genes, as well as changes in GSH/GSSG ratio and taurine concentrations
provide further evidence of increased oxidative stress in fdx1b−/−
larvae.
The altered oxidative stress response in fdx1b−/− mutants is ex-
pected to be caused by the lack of GCs. This appears surprising in light
of observations that GC excess increases reactive oxygen production
and suppresses the Nrf2 mediated antioxidant response by silencing
Nrf2 target genes [1,43]. These effects result in increased oxidative
stress and have been suggested to be a key mechanism for the adverse
effect of GCs. The increased transcript levels of the Nrf2 target gene
fth1 in the fdx1b−/− mutant larvae were restored by GC replacement
suggesting a regulatory role of GCs in the oxidative stress response in
zebraﬁsh larvae. However, the detected changes in GSH/GSSG ratioand taurine levels were only partially restored by GC replacement. Fur-
thermore, the vast majority of Nrf2 target genes and genes of glutathi-
one metabolism showed opposing transcriptional patterns between
the GC-deﬁcient fdx1b−/− and rx3 strong mutants, and thus the altered
oxidative stress levels in fdx1b−/−mutants cannot solely be explained
by the lack of GCs. Given that steroid hormone synthesis is one of the
main contributors to the production of reactive oxygen species in mito-
chondria [65], it is tempting to speculate that the detected increase in
oxidative stress in the fdx1b−/−mutant is a consequence of an increased
electron leakage due to insufﬁcient Fdx1b-mediated electron transfer
during steroidogenesis. This assumption is supported by reports in ro-
dents and human showing that defects in nicotinamide nucleotide
transhydrogenase (NNT), a gene that is involved in the maintenance of
the mitochondrial redox homeostasis, leads to disturbances in adrenal
redox status and increased levels of oxidative stress [55,56,78]. Overall,
it appears that GCs modulate the antioxidant response, but GC deﬁ-
ciency might not directly lead to oxidative stress.
Although some evidence suggests GC-dependent post-
transcriptional gene regulation in immune system and anti-
inﬂammatory pathways [70], the wider understanding of post-
transcriptional regulation of metabolic pathways by GCs remains elu-
sive. Our study identiﬁed de novo purine synthesis as a metabolic path-
way affected in fdx1b−/−mutants.We demonstrated the GC-dependent
post-transcriptional regulation of two key enzymes in this pathway,
paics and atic. The pharmacological inhibition of Gls revealed a correla-
tion between regulation of paics with changes in glutamine or
glutamine-linked pathways. This is in line with previous observations
that glutamine can induce paics expression in human lung cancer cell
lines [31]. However, glutamine levels per se seem not to induce paics
mRNA levels, as YAP transgenic zebraﬁsh which exhibit also increased
glutamine levels [12] show repressed paicsmRNA levels. Why is paics
expression differentially affected in the two conditions of glutamine ac-
cumulation? The ﬁrst committed and rate-liming entry of glutamine
into de novo purine biosynthesis is catalysed by phosphoribosyl pyro-
phosphate amidotransferase (ppat) [62]. Expression of this enzyme pos-
itively correlates with paicsmRNA levels in YAP transgenic (p= .0502)
and fdx1b−/− mutants (p = .0006). Thus, lower expression of ppat in
YAP transgenics may limit glutamine ﬂux into the purine biosynthesis
pathway,while glutamineﬂuxwould be increased in fdx1b−/−mutants.
This observation suggests that the ﬂux of glutamine into de novo purine
synthesis rather than absolute glutamine concentrations aremost likely
linked to paicsmRNA stability.
In contrast, post-transcriptional regulation of atic appears to be
glutamine-independent. miRNAs are key molecules for post-
transcriptional regulation [34], and are promising candidates in the reg-
ulation of paics and atic. Indeed, several miRNAs have been shown to
regulate glutamine metabolism through targeting glutaminase expres-
sion [27,52,66] andmay thereby affect the purine biosynthesis pathway
genes. In our study,we have identiﬁed themiRNA dre-mir-2192 as being
differentially expressed in fdx1b−/−mutants. Importantly, dre-mir-2192
has been predicted to target metabolism in ﬁsh species [39]. A murine
deletionmodel of DICER shows only a slight decrease in both transcrip-
tion and mRNA abundance of paics. The high correlation of mRNA and
pre-mRNA levels supports the assumption that the observed post-
transcriptional changes of paics in fdx1b−/− mutants are driven by a
miRNA-independent mechanism. atic shows an opposing proﬁle as
mRNA levels drop to a higher extent in DICER KO mice than those of
pre-mRNA, suggesting that miRNAs are involved in the post-
transcriptional stabilization of aticmRNA. However, a potential direct
regulation of atic by dre-mir-2192 would be rather surprising, as dre-
mir-2192would have to act through a yet undescribed mechanism sta-
bilizing the transcript rather than targeting it for degradation. Alterna-
tively, the regulation of atic by miRNAs might be indirect, for example,
involving the destabilization of another regulator of atic, which then al-
lows for stabilization of atic transcript levels. Such regulators inducing
mRNA decay have been described in the context of GCs [15,61] and
Fig. 7. Amino acid changes in plasma of patients with primary adrenal insufﬁciency overlap with changes observed in fdx1b−/−mutant larvae. (A) Hormonal features of patients with
primary adrenal insufﬁciency on hydrocortisone treatment and after 48 h interruption of therapy. (B) Levels of the amino acids asparagine (Asn), lysine (Lys), phenylalanine (Phe),
alanine (Ala), histidine (His), arginine (Arg), leucine (Leu), and methionine (Met) in human patient plasma in On and Off treatment conditions. (C) Venn diagram showing the altered
amino acids in human patients with primary insufﬁciency, fdx1b−/− and rx3 strong mutants between untreated and treated conditions. More amino acids are altered between human
and fdx1b−/− mutants (p = .02; assessed by hypergeometric testing) than between human and rx3 strong mutants (p = .18). The data for the rx3 mutants is a reanalysis from our
previously published data set [74].
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shares a seed match with atic but not paics at the 3’UTR [48]. Future
workwill be required to understandwhether and howmiRNAs regulate
the post-transcriptional regulation of atic. Overall, our identiﬁcation of
GC mediated post-transcriptional regulation of the de novo purine syn-
thesis pathway deﬁnes new research questions aiming at a detailed
mechanistic understanding of the interconnections between GC signal-
ling, glutamine metabolism and miRNA regulation.
In conclusion, our work provides a detailed characterization of the
in vivo consequences of a disrupted ferredoxin system and GCdeﬁciency on metabolism at a transcriptional, post-transcriptional
and metabolite level. Based on our characterization of two GC-
deﬁcient mutants, we propose that the fdx1b−/− and rx3 strong mu-
tant have translational capacity for future investigations into the
pathogenesis of primary and secondary adrenal insufﬁciency. Given
that zebraﬁsh is a well-known model organism for performing
high-throughput screenings, future applications of both models
might include screenings to identify compounds that speciﬁcally tar-
get the metabolic differences between patients with primary and sec-
ondary adrenal insufﬁciency.
388 M. Weger et al. / EBioMedicine 36 (2018) 376–389Supplementary data to this article can be found online at https://doi.
org/10.1016/j.ebiom.2018.09.024.
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